AcelRx Pharmaceuticals: Funding, Investors & Team (Oct 2026)
AcelRx Pharmaceuticals is a specialty pharmaceutical company, that engages in the development and commercialization of therapies for the treatment of pain and other conditions. It offers NanoTab, a tablet for oral transmucosal administration. The company also provides Sufentanil NanoTab PCA system, a sublingual patient-controlled analgesia system with a drug/device combination product candidate for the management of acute postoperative pain in the hospital settings; Sufentanil NanoTab BTP management systems for the treatment option for patients with cancer pain; and Sufentanil/Triazolam NanoTab, which provides analgesia and sedation for minor outpatient procedures. It serves patients, physicians, regulators, and payers. AcelRx Pharmaceuticals was founded in 2005 and is based in Redwood City, California.
AcelRx Pharmaceuticals has raised $17.5M across 2 funding rounds on record, the most recent an undisclosed round of $10.0M announced in Jul 2023.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
AcelRx Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Jul 2023.
AcelRx Pharmaceuticals Funding Rounds
AcelRx Pharmaceuticals raised $7.5M in an undisclosed round announced in Dec 2022.
7 months later, an undisclosed round of $10.0M was announced in Jul 2023.
AcelRx Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
AcelRx Pharmaceuticals Funding Compared to Other Biotechnology Startups
AcelRx Pharmaceuticals' latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AcelRx Pharmaceuticals in Biotechnology and Redwood City
Companies Similar to AcelRx Pharmaceuticals
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
AcelRx Pharmaceuticals Funding FAQs
What does AcelRx Pharmaceuticals do?
AcelRx Pharmaceuticals is a specialty pharmaceutical company, that engages in the development and commercialization of therapies for the treatment of pain and other conditions. It offers NanoTab, a tablet for oral transmucosal administration. The company also provides Sufentanil NanoTab PCA system, a sublingual patient-controlled analgesia system with a drug/device combination product candidate for the management of acute postoperative pain in the hospital settings; Sufentanil NanoTab BTP management systems for the treatment option for patients with cancer pain; and Sufentanil/Triazolam NanoTab, which provides analgesia and sedation for minor outpatient procedures. It serves patients, physicians, regulators, and payers. AcelRx Pharmaceuticals was founded in 2005 and is based in Redwood City, California.
How much funding has AcelRx Pharmaceuticals raised?
AcelRx Pharmaceuticals has raised $17.5M across 2 rounds on record. The most recent is an undisclosed round of $10.0M announced in Jul 2023.
When did AcelRx Pharmaceuticals last raise funding?
AcelRx Pharmaceuticals' most recent funding round on record is an undisclosed round of $10.0M, announced in Jul 2023.
Who founded AcelRx Pharmaceuticals?
FundedIQ lists Pamela Pierce Palmer (Founder) at AcelRx Pharmaceuticals.
Where is AcelRx Pharmaceuticals headquartered?
AcelRx Pharmaceuticals is based in Redwood City, California, United States.
How many employees does AcelRx Pharmaceuticals have?
AcelRx Pharmaceuticals is in the 51-100 employee band.
How does AcelRx Pharmaceuticals' funding compare to other Biotechnology startups?
AcelRx Pharmaceuticals' latest round of $10.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's AcelRx Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AcelRx Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.